Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Change in Acquisitions & Divestments (2018 - 2025)

Abeona Therapeutics (ABEO) has 8 years of Change in Acquisitions & Divestments data on record, last reported at $98.1 million in Q2 2025.

  • For Q2 2025, Change in Acquisitions & Divestments rose 473.46% year-over-year to $98.1 million; the TTM value through Sep 2025 reached $182.3 million, up 73.32%, while the annual FY2024 figure was $120.2 million, 131.28% up from the prior year.
  • Change in Acquisitions & Divestments reached $98.1 million in Q2 2025 per ABEO's latest filing, up from $54.3 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $98.1 million in Q2 2025 and bottomed at $8.7 million in Q1 2022.
  • Average Change in Acquisitions & Divestments over 5 years is $26.0 million, with a median of $19.5 million recorded in 2021.
  • Peak YoY movement for Change in Acquisitions & Divestments: plummeted 65.32% in 2022, then surged 473.46% in 2025.
  • A 5-year view of Change in Acquisitions & Divestments shows it stood at $16.2 million in 2021, then tumbled by 44.99% to $8.9 million in 2022, then skyrocketed by 67.46% to $15.0 million in 2023, then surged by 100.22% to $30.0 million in 2024, then surged by 227.41% to $98.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Acquisitions & Divestments were $98.1 million in Q2 2025, $54.3 million in Q1 2025, and $30.0 million in Q4 2024.